English  |  正體中文  |  简体中文  |  2825920  
???header.visitor??? :  31401680    ???header.onlineuser??? :  1211
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"i chin"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-16 of 16  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
國立成功大學 2023-12 Remission of refractory eosinophilic gastrointestinal disease in an eosinophilic granulomatosis with polyangiitis patient by anti-IL-5 therapy Wang;Chrong-Reen;Tsai;Hung-Wen;Wu;I-Chin
國立成功大學 2023-11 Autoimmune hepatitis and primary biliary cholangitis overlap disease in a systemic lupus erythematosus patient receiving long-term B-cell depletion therapy Wang;Chrong-Reen;Tsai;Hung-Wen;Wu;I-Chin
國立成功大學 2023-04-29 Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan Wu;Juei-Seng;Lin;Yih-Jyh;Chang;Ting-Tsung;Wang;Chung-Teng;Liu;Wen-Chun;Hsieh;Ming-Tsung;Wu;I-Chin;Chen;Po-Jun;Chen;Chiung-Yu;Lin;Sheng-Hsiang;Chuang;Chiao-Hsiung;Han;Meng-Zhi;Chen;Huang-Pin;Tsai;Hong-Ming;Kuo;Hsin-Yu
國立成功大學 2023-02 Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma Chiang;Hsueh-Chien;Lee;Yang-Cheng;Chang;Ting-Tsung;Lin;Yih-Jyh;Wu;Hung-Tsung;Wang;Chung-Teng;Chen;Chiung-Yu;Chen;Po-Jun;Hsieh;Ming-Tsung;Lin;Sheng-Hsiang;Chen;Shang-Hung;Chuang;Chiao-Hsiung;Wu;I-Chin;Hong;Tzu-Chun;Wu;Juei-Seng;Han;Meng-Zhi;Chen;Wei-Ting;Chiang;Chien-Ming;Hung;Kuan-Kai;Kuo;Hsin-Yu
國立成功大學 2022-11 Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma Kuo;Hsin-Yu;Han;Meng-Zhi;Liao;Chih-Hsiang;Lin;Yih-Jyh;Wang;Chung-Teng;Chen;Shang-Hung;Chang;Ting-Tsung;Chen;Po-Jun;Lin;Sheng-Hsiang;Chen;Chiung-Yu;Chuang;Chiao-Hsiung;Wu;I-Chin;Wu;Juei-Seng;Hong;Tzu-Chun;Hsieh;Ming-Tsung;Lee;Yang-Cheng;Wu;Hung-Tsung;Tsai;Hong-Ming
國立成功大學 2021-07 Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis Tsai;Hong-Ming;Han;Meng-Zhi;Lin;Yih-Jyh;Chang;Ting-Tsung;Chen;Chiung-Yu;Cheng;Pin-Nan;Chuang;Chiao-Hsiung;Wu;I-Chin;Chen;Po-Jun;Kang;Jui-Wen;Chiu;Yen-Cheng;Chiu;Hung-Chih;Chien;Shih-Chieh;Kuo;Hsin-Yu
國立成功大學 2021-06 Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss Wu;I-Chin;Liu;Wen-Chun;Chiu;Yen-Cheng;Chiu;Hung-Chih;Cheng;Pin-Nan;Chang;Ting-Tsung
國立成功大學 2021-03 Effectiveness and safety of ledipasvir/ sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan Chiu;Hung-Chih;Chiu;Yen-Cheng;Yang;Er-Hsiang;Chang;Ting-Tsung;Chien;Shih-Chieh;Wu;I-Chin;Wu;Chun-Hsien;Cheng;Pin-Nan
國立成功大學 2020-05 Impact of Immune Checkpoint Inhibitors with or without a Combination of Tyrosine Kinase Inhibitors on Organ-Specific Efficacy and Macrovascular Invasion in Advanced Hepatocellular Carcinoma Kuo;Hsin-Yu;Chiang;Nai-Jung;Chuang;Chiao-Hsiung;Chen;Chiung-Yu;Wu;I-Chin;Chang;Ting-Tsung;Tsai;Hong-Ming;Lin;Yih-Jyh
國立成功大學 2020-04 Genotyping of immune-related loci associated with delayed HBeAg seroconversion in immune-active chronic hepatitis B patients Liu;Wen-Chun;Wu;I-Chin;Chiu;Yen-Cheng;Tseng;Kuo-Chih;Chen;Chi-Yi;Chiu;Hung-Chih;Cheng;Pin-Nan;Chang;Ting-Tsung
國立成功大學 2019-11 Insulin Resistance Associated Disorders Pivoting Long-Term Hepatitis B Surface Antigen Decline During Entecavir Therapy Lin;Tien-Ching;Liu;Wen-Chun;Hsu;Yu-Hsiang;Lin;Jia-Jhen;Chiu;Yen-Cheng;Chiu;Hung-Chih;Cheng;Pin-Nan;Chen;Chiung-Yu;Chang;Ting-Tsung;Wu;I-Chin
國立成功大學 2019-03 Fully galactosyl-fucosyl-bisected IgG(1) reduces anti-HBV efficacy and liver histological improvement Ho;Cheng-Hsun;Chen;Shu-Hui;Tsai;Hung-Wen;Wu;I-Chin;Chang;Ting-Tsung
國立成功大學 2018-06-2 Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations Wu;I-Chin;Liu;Wen-Chun;Chang;Ting-Tsung
國立成功大學 2018-02-14 Clinical utility of hepatitis B surface antigen kinetics in treatment-naive chronic hepatitis B patients during long-term entecavir therapy Lin;Tien-Ching;Chiu;Yen-Cheng;Chiu;Hung-Chih;Liu;Wen-Chun;Cheng;Pin-Nan;Chen;Chiung-Yu;Chang;Ting-Tsung;Wu;I-Chin
國立成功大學 2017-10 Hepatocellular carcinoma-associated single-nucleotide variants and deletions identified by the use of genome-wide high-throughput analysis of hepatitis B virus Liu;Wen-Chun;Wu;I-Chin;Lee;Yen-Chien;Lin;Chih-Peng;Cheng;Ji-Hong;Lin;Yih-Jyh;Yen;Chia-Jui;Cheng;Pin-Nan;Li;Pei-Fu;Cheng;Yi-Ting;Cheng;Pei-Wen;Sun;Koun-Tem;Yan;Shu-Ling;Lin;Jia-Jhen;Yang;Jui-Chu;Chang;Kung-Chao;Ho;Cheng-Hsun;Tseng;Vincent, S.;Chang;Bill, Chia-Han;Wu;Jaw-Ching;Chang;Ting-Tsung
國立成功大學 2017-05-16 Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg- positive Patients with High Serum Fucosyl- Agalactosyl IgG Ho;Cheng-Hsun;Tsai;Hung-Wen;Lee;Chen-Yeh;Huang;Li-Juan;Chien;Rong-Nan;Wu;I-Chin;Chiu;Yen-Cheng;Liu;Wen-Chun;Cheng;Pin-Nan;Chang;Ting-Tsung;Chen;Shu-Hui

Showing items 1-16 of 16  (1 Page(s) Totally)
1 
View [10|25|50] records per page